(S)-N-(3-methyl-1-oxo-1-(thiazol-2-ylamino)butan-2-yl)-3-oxo-3,4-dihydroquinoxaline-1(2H)-carboxamide
TL;DR: (S)-N-(3-methyl-1-oxo-1-(thiazol-2-ylamino)butan-2-yl)-3-oxo-3,4-dihydroquinoxaline-1(2H)-carboxamide (CAS 1212304-85-2) is a chemical compound with molecular formula C17H19N5O3S and molecular weight 373.12 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.
N-[(2S)-3-methyl-1-oxo-1-(1,3-thiazol-2-ylamino)butan-2-yl]-3-oxo-2,4-dihydroquinoxaline-1-carboxamide
Also Known As: (S)-N-(3-methyl-1-oxo-1-(thiazol-2-ylamino)butan-2-yl)-3-oxo-3,4-dihydroquinoxaline-1(2H)-carboxamide, N-[(2S)-3-methyl-1-oxo-1-(1,3-thiazol-2-ylamino)butan-2-yl]-3-oxo-2,4-dihydroquinoxaline-1-carboxamide
| Molecular Formula | C17H19N5O3S |
|---|---|
| Molecular Weight | 373.12 g/mol |
| LogP | 2.2745 |
| Topological Polar Surface Area | 103.43 Ų |
| Hydrogen Bond Donors | 3 |
| Hydrogen Bond Acceptors | 5 |
| Rotatable Bonds | 4 |
| Exact Mass | 373.12085 |
| Heavy Atoms | 26 |
| Complexity | 821.5657 |
Chemical Identifiers
| CAS Number | 1212304-85-2 |
|---|---|
| SMILES | CC(C)[C@@H](C(=O)NC1=NC=CS1)NC(=O)N2CC(=O)NC3=CC=CC=C32 |
Product Overview
(S)-N-(3-methyl-1-oxo-1-(thiazol-2-ylamino)butan-2-yl)-3-oxo-3,4-dihydroquinoxaline-1(2H)-carboxamide (CAS 1212304-85-2), with molecular formula C17H19N5O3S and molecular weight 373.12 g/mol. IUPAC: N-[(2S)-3-methyl-1-oxo-1-(1,3-thiazol-2-ylamino)butan-2-yl]-3-oxo-2,4-dihydroquinoxaline-1-carboxamide.
Chemical Property Profile of (S)-N-(3-methyl-1-oxo-1-(thiazol-2-ylamino)butan-2-yl)-3-oxo-3,4-dihydroquinoxaline-1(2H)-carboxamide
Property Insights of (S)-N-(3-methyl-1-oxo-1-(thiazol-2-ylamino)butan-2-yl)-3-oxo-3,4-dihydroquinoxaline-1(2H)-carboxamide
The XLogP value of 2.2745 suggests moderate lipophilicity, balancing water solubility and membrane permeability for (S)-N-(3-methyl-1-oxo-1-(thiazol-2-ylamino)butan-2-yl)-3-oxo-3,4-dihydroquinoxaline-1(2H)-carboxamide. The TPSA of 103.43 Ų falls within the moderate polarity range, balancing permeability and solubility for (S)-N-(3-methyl-1-oxo-1-(thiazol-2-ylamino)butan-2-yl)-3-oxo-3,4-dihydroquinoxaline-1(2H)-carboxamide. Following Lipinski's Rule of Five, (S)-N-(3-methyl-1-oxo-1-(thiazol-2-ylamino)butan-2-yl)-3-oxo-3,4-dihydroquinoxaline-1(2H)-carboxamide has 3 hydrogen bond donor(s) and 5 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
Frequently Asked Questions
Frequently Asked Questions
What is the CAS number of (S)-N-(3-methyl-1-oxo-1-(thiazol-2-ylamino)butan-2-yl)-3-oxo-3,4-dihydroquinoxaline-1(2H)-carboxamide?
The CAS number of (S)-N-(3-methyl-1-oxo-1-(thiazol-2-ylamino)butan-2-yl)-3-oxo-3,4-dihydroquinoxaline-1(2H)-carboxamide is 1212304-85-2.
What is the molecular formula of (S)-N-(3-methyl-1-oxo-1-(thiazol-2-ylamino)butan-2-yl)-3-oxo-3,4-dihydroquinoxaline-1(2H)-carboxamide?
The molecular formula of (S)-N-(3-methyl-1-oxo-1-(thiazol-2-ylamino)butan-2-yl)-3-oxo-3,4-dihydroquinoxaline-1(2H)-carboxamide is C17H19N5O3S.
What is the molecular weight of (S)-N-(3-methyl-1-oxo-1-(thiazol-2-ylamino)butan-2-yl)-3-oxo-3,4-dihydroquinoxaline-1(2H)-carboxamide?
The molecular weight of (S)-N-(3-methyl-1-oxo-1-(thiazol-2-ylamino)butan-2-yl)-3-oxo-3,4-dihydroquinoxaline-1(2H)-carboxamide is 373.12 g/mol.
Where can I buy (S)-N-(3-methyl-1-oxo-1-(thiazol-2-ylamino)butan-2-yl)-3-oxo-3,4-dihydroquinoxaline-1(2H)-carboxamide?
You can request a quote for (S)-N-(3-methyl-1-oxo-1-(thiazol-2-ylamino)butan-2-yl)-3-oxo-3,4-dihydroquinoxaline-1(2H)-carboxamide directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.
Does KEHONG BIO offer custom synthesis for (S)-N-(3-methyl-1-oxo-1-(thiazol-2-ylamino)butan-2-yl)-3-oxo-3,4-dihydroquinoxaline-1(2H)-carboxamide?
Yes, KEHONG BIO provides custom synthesis services for (S)-N-(3-methyl-1-oxo-1-(thiazol-2-ylamino)butan-2-yl)-3-oxo-3,4-dihydroquinoxaline-1(2H)-carboxamide and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.